New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine
- The shot, named mFlusiva, is intended for adults age 50 or older
- Flu vaccines must be updated annually to best match circulating strains of the virus
COVID-19
EU regulator backs approval for Moderna’s combined COVID and flu vaccine
UK ex-PM Boris Johnson hits back at ‘incoherent’ Covid inquiry report
UK Covid inquiry says thousands of lives could have been saved
COVID-19 vaccines may help some cancer patients fight tumors
Frenchman in missing-body case gets 30 years for murdering wife
VideoUK mobile phones blare in national emergency test
David Nabarro, British physician who led UN response to Ebola and COVID-19, dies
VideoUS ends case against doctor over alleged COVID-19 vaccine scheme
China investigates Wuhan former mayor who presided over COVID-19 response
Special